Breast cancer resistance protein-mediated topotecan resistance in ovarian cancer cells.
about
Ascites Increases Expression/Function of Multidrug Resistance Proteins in Ovarian Cancer Cells.FL118, a novel camptothecin analogue, overcomes irinotecan and topotecan resistance in human tumor xenograft models.Protein profiling of ovarian cancers by immunohistochemistry to identify potential target pathways.Novel ABCG2 Antagonists Reverse Topotecan-Mediated Chemotherapeutic Resistance in Ovarian Carcinoma Xenografts.Pharmacogenomics of second-line drugs used for treatment of unresponsive or relapsed osteosarcoma patients.Metronomic oral topotecan with pazopanib is an active antiangiogenic regimen in mouse models of aggressive pediatric solid tumor.Using LC-MS/MS-based targeted proteomics to monitor the pattern of ABC transporters expression in the development of drug resistance
P2860
Q35684285-BF293CCA-1D39-49AB-887F-FB5EB589F6B1Q36309467-FA0AC810-F933-4490-8EC7-856DC397A5D4Q36928958-E9334509-D593-4B0F-BC6C-22777A09290CQ38743568-01C7152B-89C9-4861-AC52-A0F0E9070C80Q38791215-87DB9044-5D17-4E17-B3A9-DFDBCB0AF153Q39501053-562CFB2A-4898-41C3-BAED-B0B112242FD5Q58713086-3B66683C-87AC-4107-8029-97D48E0DD9D9
P2860
Breast cancer resistance protein-mediated topotecan resistance in ovarian cancer cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Breast cancer resistance protein-mediated topotecan resistance in ovarian cancer cells.
@en
type
label
Breast cancer resistance protein-mediated topotecan resistance in ovarian cancer cells.
@en
prefLabel
Breast cancer resistance protein-mediated topotecan resistance in ovarian cancer cells.
@en
P2093
P1476
Breast cancer resistance protein-mediated topotecan resistance in ovarian cancer cells.
@en
P2093
P304
P356
10.1111/J.1525-1438.2005.00260.X
P577
2005-11-01T00:00:00Z